Apigenin inhibits infectious bronchitis virus replication in ovo
M.J. Saadh, S.A. Jaber, M. Alaraj, A. Alafnan Faculty of Pharmacy, Middle East University, Amman, Jordan. msaadeh@meu.edu.jo
OBJECTIVE: Infectious bronchitis virus (IBV), for which no effective drugs are available, is among the most important causes of economic loss within the poultry industry. Apigenin is a flavonoid that can be isolated from plants. Apigenin has low toxicity with anti-viral activity. However, the effects of apigenin against IBV remain unclear.
MATERIALS AND METHODS: Thus, here we investigate the anti-viral effect of apigenin on IBV using 10 day-old embryonated eggs by determining the virus titer by embryo infective doses50 (EID50/mL) and determining IBV genomes copy number (per µL) of allantoic fluid.
RESULTS: We found that apigenin protected embryonated eggs from IBV. Additionally, apigenin reduced the log titer of the IBV with a significant correlation of up to 9.4 times at 2 µg/egg. Also, apigenin appears to significantly reduce IBV genomes copy number (per µL) in the allantoic fluid.
CONCLUSIONS: Apigenin may be a promising approach for the treatment of IBV, since it protects embryonated eggs from IBV in ovo and suppresses viral replication.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M.J. Saadh, S.A. Jaber, M. Alaraj, A. Alafnan
Apigenin inhibits infectious bronchitis virus replication in ovo
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 15
Pages: 5367-5371
DOI: 10.26355/eurrev_202208_29403